Joseph E. Payne and the Intellectual Property Strategy Behind Arcturus Therapeutics’ Global RNA Innovation Footprint
In the biotech industry, intellectual property (IP) serves as both protection and a competitive tool. In an area where technology can be duplicated fast and development cycles are accelerated, a firm’s capacity to gain and protect patents often constitutes its standing in the market. For RNA biotechs, where technologies such as lipid nanoparticle delivery and…
